1-4 of 4
Patrik Brodin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Patients with TP53 Mutated Relapsed/Refractory AML with Lintuzumab-Ac225 in Combination with CLAG-M Following Venetoclax Plus Hypomethylating Agent Therapy

Sameem Abedin, Guru Subramanian Guru Murthy, Mehdi Hamadani, Laura C. Michaelis, Karen-Sue Carlson, Lyndsey Runaas, Katelyn Gauger, Avinash Desai, Mary Chen, Patrik Brodin, Kate L Li, Mojisola Rotibi, Umar Sayeed, Alexandra M. Harrington, Ehab L. Atallah
Journal: Blood
Blood (2024) 144 (Supplement 1): 4258.
https://doi.org/10.1182/blood-2024-201559
Published: 2024
Journal Articles

Lintuzumab-Ac225 Exerts Mutation Agnostic Antileukemic Activity in Preclinical Models of AML

Amanda Chin, Rubin Jiao, Kevin J.H. Allen, Jason Li, Mary Chen, Madhuri Vusirikala, Avinash Desai, Le-Cun Xu, Patrik Brodin, Monideepa Roy, Mackenzie Malo, Denis Beckford-Vera, Ekaterina Dadachova, Helen Kotanides
Journal: Blood
Blood (2024) 144 (Supplement 1): 5801.
https://doi.org/10.1182/blood-2024-204282
Published: 2024
Journal Articles

High-Dose Targeted Radiation with 131 I-Apamistamab Prior to HCT Demonstrated a Dose-Response for Durable Complete Remission in Patients with R/R AML

Mark R. Litzow, George Chen, Boglarka Gyurkocza, Rajneesh Nath, Stuart Seropian, Hannah Choe, Camille N. Abboud, Nebu Koshy, Ben K. Tomlinson, Sunil Abhyankar, James M. Foran, Sameem Abedin, Zaid Al-Kadhimi, Partow Kebriaei, Mitchell Sabloff, Johnnie J. Orozco, Katarzyna Joanna Jamieson, Margarida Magalhaes-Silverman, Koen Van Besien, Michael W. Schuster, Arjun D. Law, Sebastian A. Mayer, Hillard M. Lazarus, Eugene Leung, Ming-Kai Chen, Mona Natwa, Jennifer Spross, Kate L Li, Norman Nagl, Elaina Haeuber, Madhuri Vusirikala, Akash Nahar, Brenda M. Sandmaier, John Pagel, Sergio A. Giralt, Avinash Desai, Richard L. Wahl, Neeta Pandit-Taskar, Patrik Brodin, Patrick J. Stiff
Journal: Blood
Blood (2023) 142 (Supplement 1): 3529.
https://doi.org/10.1182/blood-2023-189040
Published: 2023
Journal Articles

Lintuzumab-Ac225, a CD33-Directed Antibody Radiotherapy, Targets AML in a Mutation Agnostic Manner

Amanda Chin, Rubin Jiao, Kevin J.H. Allen, Jason Li, Mary Chen, Madhuri Vusirikala, Le-Cun Xu, Patrik Brodin, Monideepa Roy, Mackenzie Malo, William Van der Touw, Ekaterina Dadachova, Denis Beckford-Vera, Helen Kotanides
Journal: Blood
Blood (2023) 142 (Supplement 1): 5750.
https://doi.org/10.1182/blood-2023-187498
Published: 2023